Literature DB >> 3179172

Interaction of salicylate and corticosteroids in man.

R O Day1, G Harris, M Brown, G G Graham, G D Champion.   

Abstract

Corticosteroids have been reported to decrease the plasma concentrations of salicylate when salicylates have been administered chronically at high doses. In the present study, two single, oral doses of sodium salicylate, 10 mg kg-1 were administered to six adult subjects with a variety of inflammatory conditions both before and during treatment with daily oral doses of prednisone (12-60 mg). Concomitant prednisone therapy did not increase the whole body clearance of single doses of salicylate in these subjects (0.0275 +/- 0.08 l kg-1 h-1 before prednisone; 0.0247 +/- 0.03 l kg-1 h-1 during prednisone therapy; P greater than 0.05). These results indicate that corticosteroids do not alter the clearance of single doses of salicylate in man.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3179172      PMCID: PMC1386548          DOI: 10.1111/j.1365-2125.1988.tb05286.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  13 in total

1.  Patterns of plasma concentrations and urinary excretion of salicylate in rheumatoid arthritis.

Authors:  G G Graham; G D Champion; R O Day; P D Paull
Journal:  Clin Pharmacol Ther       Date:  1977-10       Impact factor: 6.875

2.  Failure of prednisone to alter plasma salicylate concentrations in dogs.

Authors:  D K Day; H E Williamson; R J Roberts
Journal:  J Pharm Sci       Date:  1976-05       Impact factor: 3.534

3.  Corticosteroids-salicylate interaction in a case of juvenile rheumatoid arthritis.

Authors:  G Koren; C Roifman; E Gelfand; S Lavi; D Suria; L Stein
Journal:  Ther Drug Monit       Date:  1987-06       Impact factor: 3.681

4.  Limited capacity for salicyl phenolic glucuronide formation and its effect on the kinetics of salicylate elimination in man.

Authors:  G Levy; T Tsuchiya; L P Amsel
Journal:  Clin Pharmacol Ther       Date:  1972 Mar-Apr       Impact factor: 6.875

5.  Urine pH and salicylate therapy.

Authors:  G Levy; J R Leonards
Journal:  JAMA       Date:  1971-07-05       Impact factor: 56.272

6.  Value of monitoring plasma salicylate levels in treating juvenile rheumatoid arthritis. Observations in 42 cases.

Authors:  M Bardare; G U Cislaghi; M Mandelli; F Sereni
Journal:  Arch Dis Child       Date:  1978-05       Impact factor: 3.791

7.  Effect of corticosteroids on blood salicylate concentration.

Authors:  J R Klinenberg; F Miller
Journal:  JAMA       Date:  1965-11-08       Impact factor: 56.272

8.  Pharmacokinetics of salicylate elimination in man.

Authors:  G Levy
Journal:  J Pharm Sci       Date:  1965-07       Impact factor: 3.534

9.  Determination of acetylsalicylic acid and salicylic acid in plasma.

Authors:  M Rowland; S Riegelman
Journal:  J Pharm Sci       Date:  1967-06       Impact factor: 3.534

10.  Effect of antacid and ascorbic acid on serum salicylate concentration.

Authors:  P D Hansten; W L Hayton
Journal:  J Clin Pharmacol       Date:  1980 May-Jun       Impact factor: 3.126

View more
  3 in total

Review 1.  Drug interactions involving aspirin (acetylsalicylic acid) and salicylic acid.

Authors:  J O Miners
Journal:  Clin Pharmacokinet       Date:  1989-11       Impact factor: 6.447

2.  Honorary Professor Garry Graham.

Authors:  Richard O Day; Kenneth M Williams; Kieran F Scott
Journal:  Inflammopharmacology       Date:  2021-09-17       Impact factor: 4.473

Review 3.  Adverse drug interactions with nonsteroidal anti-inflammatory drugs (NSAIDs). Recognition, management and avoidance.

Authors:  A G Johnson; P Seideman; R O Day
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.